Repurposing bosentan as an anticancer agent: EGFR/ERK/c‐Jun modulation inhibits NSCLC tumor growth

Marwa M. Khalaf(Beni-Suef University), Maha M. Abdel‐Fattah(Beni-Suef University)
Fundamental and Clinical Pharmacology
January 12, 2025
Cited by 3


Related Papers

No related papers found

Powered by citation graph analysis